ORIGINAL RESEARCH
Accepted on 03 Mar 2025
Pan-cancer analysis of co-inhibitory molecules revealing their potential prognostic and clinical values in immunotherapy
doi 10.3389/fimmu.2025.1544104
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Beyond PD-1: Novel Checkpoint Receptors and Ligands as Targets for Immunotherapy, Volume II
Community Series in Beyond PD-1: Novel Checkpoint Receptors and Ligands as Targets for Immunotherapy, Volume II
754
Total downloads
2,634
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 31 Jan 2025
It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
doi 10.3389/fimmu.2025.1495907
- 694 views
REVIEW
Published on 26 Nov 2024
Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials
doi 10.3389/fimmu.2024.1501613
- 788 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: